Medical Properties Trust Inc (NYSE: MPT) touched a 52-week low of $3.89 on Wednesday, trading roughly 40% below its 52-week high of $6.47. The healthcare real estate investment trust has shed 17% year to date, nearly 25% over the past six months, and 15.4% over the past year.
Shares have been weighed down by a challenging debt-refinancing effort. In August, the company announced a private placement and exchange transaction closing, issuing $2.4 billion in new 9.25% senior secured notes maturing in 2032. The proceeds are intended to redeem senior notes coming due in 2026 and partially retire notes due in 2027. Management also noted approximately $1.5 billion in unsecured notes are being refinanced from maturities between 2027 and 2031 as part of ongoing debt management heading into 2027.
On Tuesday, MPT reported second-quarter 2026 revenue of $259.28 million, exceeding Wall Street's expectation of $248.01 million. However, the company posted a minor loss of $0.01 per share, missing the projected slight profit of $0.0047 per share. Normalized funds from operations came in at $0.15 per share, in line with estimates and up from $0.14 per share in the prior quarter. Management highlighted strong growth among post-acute operators, with EBITDARM rising more than $70 million year over year.
MPT has maintained a dividend for 22 consecutive years and currently offers a 9% yield, a figure that has drawn income-focused investors even as the stock price has declined.
The combination of a depressed share price, elevated dividend yield, and a multi-year debt restructuring program continues to define the investment thesis for MPT, which owns and operates hospitals and medical facilities across North America and Europe.
